Braxia Scientific Corp C.BRAX

Braxia Scientific Reports Q3 2022 Financial Results

[Betteryear2]

• Achieved milestone with the start of landmark psilocybin clinical trial in Q3 2021- more than a dozen patients receive initial dose to date in first-ever Health Canada-approved, multi-dose psilocybin clinical trial in Canada
   
• Braxia Scientific funded psilocybin trial establishes psilocybin treatment framework for patients with Treatment Resistant Depression (TRD), provides patients immediate access to psychedelic treatments, and training for new therapists providing psilocybin-assisted therapy
   
• Clinics administer ~5,500 ketamine treatments to date across growing patient base in Canada

TORONTO, March 1, 2022 /PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, today announced the filing of its fiscal third-quarter results for the three-month period ending December 31, 2021. Complete financial statements along with related management discussion and analysis can be found in the System for Electronic Document Analysis and Retrieval (SEDAR), the electronic filing system for the disclosure documents of issuers across Canada, at www.SEDAR.com.

https://www.prnewswire.com/news-releases/braxia-scientific-reports-q3-2022-financial-results-company-leads-in-psychedelic-research-access-and-therapist-training-with-first-multi-dose-psilocybin-trial-in-canada-301493386.html

 

[newcoin]

Yes, a lot of positive achievements. We need to look past the manipulated share price, for now. Their work with psilocybin will pay off big time as will their association with Big Pharma.

[cautiousguy]

https://www.prnewswire.com/news-releases/braxia-scientific-reports-q3-2022-financial-results-company-leads-in-psychedelic-research-access-and-therapist-training-with-first-multi-dose-psilocybin-trial-in-canada-301493386.html NEWS PROVIDED BY Braxia Scientific Corp.  Mar 01, 2022, 17:20 ET So you know it must be unbiased.   You might go to SEDAR